-
1
-
-
23844515938
-
Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma
-
TAN HY, LIU J, WU SM, LUO HS: Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma. World J Gastroenterol 2005; 11: 4689-4692.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 4689-4692
-
-
Tan, H.Y.1
Liu, J.2
Wu, S.M.3
Luo, H.S.4
-
2
-
-
0035204883
-
DC: The molecular basis and potential role of survivin in cancer diagnosis and therapy
-
doi:101016/S1471-4914(01)02243-2
-
ALTIERI DC: The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542-547. doi:10.1016/S1471-4914(01)02243-2
-
(2001)
Trends Mol Med
, vol.7
, pp. 542-547
-
-
Altier, I.1
-
3
-
-
33947426098
-
Survivin: A promising tumor biomarker
-
doi:10.1016/j.canlet.2006.12020
-
DUFFY MJ, O'DONOVAN N, BRENNAN DJ, GALLAGHER WM, RYAN BM: Survivin: A promising tumor biomarker. Cancer Lett 2007; 249: 49-60. doi:10.1016/j.canlet.2006.12.020
-
(2007)
Cancer Lett
, vol.249
, pp. 49-60
-
-
Duffy, M.J.1
O'Donovan, N.2
Brennan, D.J.3
Gallagher, W.M.4
Ryan, B.M.5
-
4
-
-
0031984247
-
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation
-
ADIDA C, CROTTY PL, MCGRATH J, BERREBI D, DIEBOLD J et al.: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152: 43-49.
-
(1998)
Am J Pathol
, vol.152
, pp. 43-49
-
-
Adida, C.1
Crotty, P.L.2
McGrath, J.3
Berrebi, D.4
Diebold, J.5
-
5
-
-
4544260238
-
A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells
-
XU Y, FANG F, LUDEWIG G, JONES G, JONES D: A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 2004; 23: 527-537.
-
(2004)
DNA Cell Biol
, vol.23
, pp. 527-537
-
-
Xu, Y.1
Fang, F.2
Ludewig, G.3
Jones, G.4
Jones D5
-
6
-
-
0032706622
-
Analysis of human transcriptomes
-
doi:10.1038/70487
-
VELCULESCU VE, MADDEN SL, ZHANG L, LASH AE, YU J et al.: Analysis of human transcriptomes. Nat Genet 1999; 23: 387-388. doi:10.1038/70487
-
(1999)
Nat Genet
, vol.23
, pp. 387-388
-
-
Velculescu, V.E.1
Madden, S.L.2
Zhang, L.3
Lash, A.E.4
Yu, J.5
-
7
-
-
70349750124
-
Expression of antiapoptotic protein survivin in malignant melanoma
-
doi:10.2478/s11756-009-0134-3
-
ADAMKOV M, LAUKO L, RAJCANI J, BALENTOVA S, RYBAROVA S et al. Expression of antiapoptotic protein survivin in malignant melanoma. Biologia 2009a; 64: 840-844. doi:10.2478/s11756-009-0134-3
-
(2009)
Biologia
, vol.64
, pp. 840-844
-
-
Adamkov, M.1
Lauko, L.2
Rajcani J.Alentova, S.3
Rybarova, S.4
-
8
-
-
65649131590
-
Expression pattern of anti-apoptotic protein survivin in dysplastic nevi
-
doi:10.4149/neo_2009_02_130
-
ADAMKOV M, LAUKO L, BALENTOVA S, PEC J, PEC M et al.: Expression pattern of anti-apoptotic protein survivin in dysplastic nevi. Neoplasma 2009b; 56: 130-135. doi:10.4149/neo_2009_02_130
-
(2009)
Neoplasma
, vol.56
, pp. 130-135
-
-
Adamkov, M.1
Lauko, L.2
Balentova, S.3
Pec, J.4
Pec, M.5
-
9
-
-
0030746636
-
A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma
-
doi:101038/nm0897-917
-
AMBROSINI G, ADIDA C, ALTIERI DC: A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Net Med 1997; 3: 917-921. doi:10.1038/nm0897-917
-
(1997)
Net Med
, vol.3
, pp. 917-921
-
-
Ambrosini, G.1
Adida, C.2
Altieri, D.C.3
-
10
-
-
34249790115
-
Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma
-
doi:10.1111/j.1365-2559.2007.02695.x
-
PIRAS F, MURTAS D, MINERBA L, UGALDE J, FLORIS C et al.: Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Histopathology 2007; 50: 835-842. doi:10.1111/j.1365-2559.2007.02695.x
-
(2007)
Histopathology
, vol.50
, pp. 835-842
-
-
Piras, F.1
Murtas, D.2
Minerba, L.3
Ugalde, J.4
Floris, C.5
-
11
-
-
4344636689
-
Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer
-
DABROWSKI A, FILIP A, ZGODZINSKI W, DABROVSKA M, POLANSKA D ET AL.: Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer. Folia Histochem Cytobiol 2004; 42: 169-172.
-
(2004)
Folia Histochem Cytobiol
, vol.42
, pp. 169-172
-
-
Dabrowski, A.1
Filip, A.2
Zgodzinski, W.3
Dabrovska, M.4
Polanska, D.5
-
12
-
-
0038030728
-
Prognostic importance of survivin in breast cancer
-
doi:10.1038/sj.bjc.6600776
-
KENNEDY SM, O'DRISCOLL L, PURCELL R, FITZ-SIMONS N, MCDERMOTT EW et al.: Prognostic importance of survivin in breast cancer. Br J Cancer 2003; 88: 1077-1083. doi:10.1038/sj.bjc.6600776
-
(2003)
Br J Cancer
, vol.88
, pp. 1077-1083
-
-
Kennedy, S.M.1
O'Driscoll, L.2
Purcell, R.3
Fitz-Simons, N.4
McDermott, E.W.5
-
13
-
-
2342431243
-
Expression of survivin, Bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a)
-
KAYASELCUK F, NURSAL TZ, POLAT A, NOYAN T, YILDIRIM S et al.: Expression of survivin, Bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a). J Exp Clin Cancer Res 2004; 23: 105-112.
-
(2004)
J Exp Clin Cancer Res
, vol.23
, pp. 105-112
-
-
Kayaselcuk, F.1
Nursal, T.Z.2
Polat, A.3
Noyan, T.4
Yildirim, S.5
-
14
-
-
42549115241
-
Survivin expression in breast carcinoma: Correlation with apoptosis and prognosis
-
doi:10.1097/PAI0b013e3180c317bc
-
NASSAR A, SEXTON D, COTSONIS G, COHEN C: Survivin expression in breast carcinoma: correlation with apoptosis and prognosis. Appl Immunohistochem Mol Morphol 2008a; 16: 221-226. doi:10.1097/PAI.0b013e3180c317bc
-
(2008)
Appl Immunohistochem Mol Morphol
, vol.16
, pp. 221-226
-
-
Nassar, A.1
Sexton, D.2
Cotsonis, G.3
Cohen C4
-
15
-
-
14844311208
-
Nuclear or cytoplasmic expression of survivin: What is the significance?
-
doi:10.1002/ijc.20768
-
LI F, YANG J, RAMNATH N, JAVLE MM, TAN D: Nuclear or cytoplasmic expression of survivin: What is the significance? Int J Cancer 2005; 114: 509-512. doi:10.1002/ijc.20768
-
(2005)
Int J Cancer
, vol.114
, pp. 509-512
-
-
Li, F.1
Yang, J.2
Ramnath, N.3
Javle, M.M.4
Tan, D.5
-
16
-
-
46749155554
-
Survivin and caspase-3 expression in breast cancer: Correlation with prognosis parameters, proliferation, angiogenesis, and outcome
-
doi:10.1097/PAI0b013e318032ea73
-
NASSAR A, LAWSON D, COTSONIS G, COHEN C: Survivin and caspase-3 expression in breast cancer: correlation with prognosis parameters, proliferation, angiogenesis, and outcome. Appl Immunohistochem Mol Morphol 2008b; 16: 113-120. doi:10.1097/PAI.0b013e318032ea73
-
(2008)
Appl Immunohistochem Mol Morphol
, vol.16
, pp. 113-120
-
-
Nassar, A.1
Lawson, D.2
Cotsonis, G.3
Cohen C4
-
17
-
-
50249145879
-
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
-
doi:10.1158/1078-0432.CCR-07-1760
-
BRENNAN DJ, REXHEPAJ E, O'BRIEN SL, MCSHERRY E, O'CONNOR DP et al.: Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer. Clin Cancer Res 2008; 14: 2681-2689. doi:10.1158/1078-0432.CCR-07-1760
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2681-2689
-
-
Brennan, D.J.1
Rexhepaj, E.2
O'Brien, S.L.3
McSherry, E.4
O'Connor, D.P.5
-
18
-
-
14844299471
-
Expression of survivin in different stages of carcinogenesis and progression of breast cancer
-
ZHANG SQ, QIANG SY, YANG WB, JIANG JT, JI ZZ: Expression of survivin in different stages of carcinogenesis and progression of breast cancer. Ai Zheng 2004; 23: 697-700.
-
(2004)
Ai Zheng
, vol.23
, pp. 697-700
-
-
Zhang, S.Q.1
Qiang, S.Y.2
Yang, W.B.3
Jiang, J.T.4
Ji, Z.Z.5
-
19
-
-
76549124241
-
Expression of survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients
-
doi:10.4103/0019-535958877
-
RANADE KJ, NERURKAR AV, PHULPAGAR MD, SHIRSAT NV: Expression of survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients. Indian J Med Sci 2009; 63: 481-490. doi:10.4103/0019-5359.58877
-
(2009)
Indian J Med Sci
, vol.63
, pp. 481-490
-
-
Ranade, K.J.1
Nerurkar, A.V.2
Phulpagar, M.D.3
Shirsat, N.V.4
-
20
-
-
33747144045
-
Expression of survivin and clinical correlation in patients with breast cancer
-
doi:10.1016/j.biopha.2006.06.008
-
SOHN DM, KIM SY, BAEK MJ, LIM CW, LEE MH et al.: Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother 2006; 60: 289-292. doi:10.1016/j.biopha.2006.06.008
-
(2006)
Biomed Pharmacother
, vol.60
, pp. 289-292
-
-
Sohn, D.M.1
Kim, S.Y.2
Baek, M.J.3
Lim, C.W.4
Lee, M.H.5
-
21
-
-
0033194723
-
Communication: Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin
-
doi:10.1046/j.1523-1747.1999.00711.x
-
CHIODINO C, CESINARO AM, OTTANI D, FANTINI F, GIANNETTI A et al.: Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 1999; 113: 415-418. doi:10.1046/j.1523-1747.1999.00711.x
-
(1999)
J Invest Dermatol
, vol.113
, pp. 415-418
-
-
Chiodino, C.1
Cesinaro, A.M.2
Ottani, D.3
Fantini, F.4
Giannetti, A.5
-
22
-
-
0033870417
-
Control of apoptosis during angiogenesis by survivin expression in endothelial cells
-
O'CONNOR DS, SCHECHNER JS, ADIDA C, MESRI M, ROTHERMEL AL et al.: Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 2000; 156: 393-398.
-
(2000)
Am J Pathol
, vol.156
, pp. 393-398
-
-
O'Connor, D.S.1
Schechner, J.S.2
Adida, C.3
Mesri, M.4
Rothermel, A.L.5
-
23
-
-
13244262645
-
Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
-
doi:10.1038/sj.bjc.6602314
-
Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J et al.: Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer. Br J Cancer 2005; 17: 120-124. doi:10.1038/sj.bjc.6602314
-
(2005)
Br J Cancer
, vol.17
, pp. 120-124
-
-
Ryan, B.1
O'Donovan, N.2
Browne, B.3
O'Shea, C.4
Crown, J.5
-
24
-
-
6344221309
-
Cell survival in the absence of survivin
-
doi:10.1073/pnas.0406665101
-
Yang D, Welm A, Bishop JM: Cell survival in the absence of survivin. Proc Natl Acad Sci 2004; 101: 15100-15105. doi:10.1073/pnas.0406665101
-
(2004)
Proc Natl Acad Sci
, vol.101
, pp. 15100-15105
-
-
Yang, D.1
Welm, A.2
Bishop, J.M.3
-
25
-
-
0032506524
-
Control of apoptosis and mitotic spindle checkpoint by survivin
-
doi:10.1038/25141
-
Li F, Ambrosini G, Chu EY, Plescia J, Tognin S et al.: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584. doi:10.1038/25141
-
(1998)
Nature
, vol.396
, pp. 580-584
-
-
Li, F.1
Ambrosini, G.2
Chu, E.Y.3
Plescia, J.4
Tognin, S.5
-
26
-
-
0345737064
-
Survivin and Bcl-2 expression in prostatic adenocarcinomas
-
Kaur P, Kallakury BS, Sheehan CE, Fisher HA, Kaufman Rp JR et al.: Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med 2004; 128: 39-43.
-
(2004)
Arch Pathol Lab Med
, vol.128
, pp. 39-43
-
-
Kaur, P.1
Kallakury, B.S.2
Sheehan, C.E.3
Fisher, H.A.4
Kaufman Jr, R.P.5
-
27
-
-
9644278114
-
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
-
Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC: Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004; 114:1117-1127.
-
(2004)
J Clin Invest
, vol.114
, pp. 1117-1127
-
-
Dohi, T.1
Beltrami, E.2
Wall, N.R.3
Plescia, J.4
Altieri, D.C.5
-
28
-
-
33644524974
-
Nuclear expression of the antiapoptoptic protein survivin in malignant melanoma
-
doi:10.1002/cncr.21727
-
DING Y, PRIETO VG, ZHANG PS, ROSENTHAL S, SMITH KJ et al.: Nuclear expression of the antiapoptoptic protein survivin in malignant melanoma. Cancer 2006; 106:1123-1129. doi:10.1002/cncr.21727
-
(2006)
Cancer
, vol.106
, pp. 1123-1129
-
-
Ding, Y.1
Prieto, V.G.2
Zhang, P.S.3
Rosenthal, S.4
Smith, K.J.5
-
29
-
-
33845971510
-
Nuclear export is essential for the tumor-promoting activity of survivin
-
doi:10.1096/fj.06-5741com
-
KNAUER SK, KRÄMER OH, KNÖSEL T, ENGELS K, RÖDEL F et al.: Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J 2007; 21: 207-216. doi:10.1096/fj.06-5741com
-
(2007)
FASEB J
, vol.21
, pp. 207-216
-
-
Knauer, S.K.1
Krämer, O.H.2
Knösel, T.3
Engels, K.4
Rödel, F.5
-
30
-
-
33751549838
-
The survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function
-
doi:10.1038/sj.embor7400824
-
KNAUER SK, BIER C, HABTEMICHAEL N, STAUBER RH: The survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 2006; 7: 1259-1265. doi:10.1038/sj.embor.7400824
-
(2006)
EMBO Rep
, vol.7
, pp. 1259-1265
-
-
Knauer, S.K.1
Bier, C.2
Habtemichael, N.3
Stauber, R.H.4
-
31
-
-
34547469911
-
Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast
-
AL-JOUDI FS, ISKANDAR ZA, HASNAN J, RUSLI J, KAMAL Y et al.: Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Singapore Med J 2007; 48: 607-614.
-
(2007)
Singapore Med J
, vol.48
, pp. 607-614
-
-
Al-Joudi, F.S.1
Iskandar, Z.A.2
Hasnan, J.3
Rusli, J.4
Kamal, Y.5
-
32
-
-
31444451074
-
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
-
doi:10.1038/sj.bjc6602932
-
BARNES N, HAYWOOD P, FLINT P, KNOX WF, BUNDRED NJ: Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer 2006; 94: 253-258. doi:10.1038/sj.bjc.6602932
-
(2006)
Br J Cancer
, vol.94
, pp. 253-258
-
-
Barnes, N.1
Haywood, P.2
Flint, P.3
Knox, W.F.4
Bundred, N.J.5
-
33
-
-
0034968363
-
Clinical uses of tumor markers: A critical review
-
doi:101080/20014091084218
-
DUFFY MJ: Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38: 225-262. doi:10.1080/20014091084218
-
(2001)
Crit Rev Clin Lab Sci
, vol.38
, pp. 225-262
-
-
Duffy, M.J.1
-
34
-
-
52649172153
-
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
-
doi:10.1158/1078-0432CCR-08-0746
-
MITA AC, MITA MM, NAWROCKI ST, GILES FJ: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5005. doi:10.1158/1078-0432.CCR-08-0746
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5000-5005
-
-
Mita, A.C.1
Mita, M.M.2
Nawrocki, S.T.3
Giles, F.J.4
|